Upgrade to SI Premium - Free Trial

Lazard Capital Downgrades Edwards Lifesciences (EW) to Neutral

April 24, 2013 6:46 AM
Lazard Capital downgraded Edwards Lifesciences (NYSE: EW) from Buy to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles